Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze CADE stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CADE investment potential.

What is CADE stock price today?

Get real-time CADE stock price, historical data, and price charts on Financhill. Track CADE performance with our advanced analysis tools.

Is CADE a good investment?

Evaluate CADE investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CADE stock?

To buy CADE stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CADE?

View detailed market capitalization data and company valuation metrics for CADE on our comprehensive analysis page.

What is the P/E ratio of CADE?

Use our fundamental analysis tools to view CADE P/E ratio and compare valuation metrics with industry peers.

What are CADE earnings?

View CADE earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Cadence Bank 10K Form

Buy

CADE
Cadence Bank

Last Price:

$42.02

Seasonality Move:

2.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-11-09	10Q	CADE/Cadence Bank Quarterly
2020-08-10	10Q	CADE/Cadence Bank Quarterly
2020-05-11	10Q	CADE/Cadence Bank Quarterly
2020-02-28	10K	CADE/Cadence Bank Annual
2019-11-12	10Q	CADE/Cadence Bank Quarterly
2019-08-09	10Q	CADE/Cadence Bank Quarterly

Receive CADE News And Ratings

See the #1 stock for the next 7 days that we like better than CADE

CADE Financial Statistics

Sales & Book Value

Annual Sales:	$3B
Cash Flow:	$173.4M
Price / Cash Flow:	15.5
Annual Sales:	$31.75
Price / Book:	1.32

Profitability

EPS (TTM):	2.77020
Net Income (TTM):	$530.4M
Gross Margin:	$0
Return on Equity:	9.19%
Return on Assets:	1.07%

Cadence Bank Earnings Forecast

Key Cadence Bank Financial Ratios

The Gross Profit Margin over the past 40 years for CADE is 0.00%.
The Selling, General & Administrative Expenses for CADE have been equal to 0.00% of Gross Profit Margin.
The Interest Expense is 28.59% of Operating Income.
The Net Earning history of CADE is 17.74% of Total Revenues.
Per Share Earnings over the last 41 years have been positive in 28 years.

Cadence Bank Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Banks
Sector:	Financials
Current Symbol:	CADE
CUSIP:	12739A
Website:	cadencebank.com

Debt

Debt-to-Equity Ratio:	0.38
Current Ratio:	0.07
Quick Ratio:	0

Price-to-Earnings

Trailing P/E Ratio:	15.17
Forward P/E Ratio:	12.18

CADE Technical Analysis vs Fundamental Analysis

Buy

Cadence Bank (CADE) is a Buy

Is Cadence Bank a Buy or a Sell?

Cadence Bank stock is rated a Buy

The current Cadence Bank [CADE] share price is $42.03. The Score for CADE is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.